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Abstract
During atherogenesis and vascular inflammation quiescent platelets are activated to increase the surface expression and
ligand affinity of the integrin aIIbb3 via inside-out signaling. Diverse signals such as thrombin, ADP and epinephrine
transduce signals through their respective GPCRs to activate protein kinases that ultimately lead to the phosphorylation of
the cytoplasmic tail of the integrin aIIbb3 and augment its function. The signaling pathways that transmit signals from the
GPCR to the cytosolic domain of the integrin are not well defined. In an effort to better understand these pathways, we
employed a combination of proteomic profiling and computational analyses of isolated human platelets. We analyzed ten
independent human samples and identified a total of 1507 unique proteins in platelets. This is the most comprehensive
platelet proteome assembled to date and includes 190 membrane-associated and 262 phosphorylated proteins, which were
identified via independent proteomic and phospho-proteomic profiling. We used this proteomic dataset to create a platelet
protein-protein interaction (PPI) network and applied novel contextual information about the phosphorylation step to
introduce limited directionality in the PPI graph. This newly developed contextual PPI network computationally
recapitulated an integrin signaling pathway. Most importantly, our approach not only provided insights into the mechanism
of integrin aIIbb3 activation in resting platelets but also provides an improved model for analysis and discovery of PPI
dynamics and signaling pathways in the future.
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Introduction
Platelets are key initiators of hemostatic mechanisms that repair
injury to the vasculature. Platelets also play a central role in
cardiovascular diseases, cancer, and stroke, which account for the
major mortality and morbidity in the United States [1,2].
Additionally, platelets modulate inflammatory pathways to initiate,
sustain and accelerate a number of inflammatory diseases, such as
atherosclerosis [3].
Platelets are enucleate cells that are characteristically small and
discoidal in resting state and normally circulate at levels of
approximately 1502400610
9/L in blood [4]. Platelets rely on
integrin aIIbb3 (also known as glycoprotein GPIIb/IIIa) to
perform their primary biological function, which is to help seal
and repair the circulatory system after vascular injury [5]. Defects
in platelet function, such as impaired adhesion or aggregation, are
also primarily mediated by the integrin aIIbb3. A number of
controls, both internal and external, keep the platelets in a resting
state during circulation and prevent intracellular signals from
inappropriately activating the integrins [6], through the tight
regulation of the cytosolic Ca
2+ concentration, the activity of
intracellular phosphatases that limit signaling through kinase-
dependent pathways and the presence of extracellular ADPases
that hydrolyze released ADP.
Upon a break in the integrity of the vascular endothelial cell
lining, the underlying collagen fibrils of the extracellular matrix
(ECM) are exposed to and interact with the circulating platelets,
which leads to platelet adhesion to collagen, via the platelet
collagen receptor integrin a2b1 (also known as glycoprotein
(GPIa/IIa)). In addition, the interaction provides the platelets with
PLoS ONE | www.plosone.org 1 October 2009 | Volume 4 | Issue 10 | e7627a strong activation signal, which induces the platelets to change
shape, to spread along the collagen fibrils and to secrete
thromboxane A2 and ADP into the circulation, and to induce
conformational changes in the abundant second platelet integrin
aIIbb3. Normally present in an inactive conformation, integrin
activation facilitates the binding of circulating coagulation protein
fibrinogen (a process referred to as ‘‘inside-out signaling’’ [6]).
Simultaneous binding of two integrin aIIbb3 receptors by
fibrinogen initiates the process of platelet aggregation [7].
Subsequently, a series of platelet intracellular signaling events
are initiated and propagated, including activation of the various
tyrosine and serine/threonine kinases and the protein phospha-
tases (so called ‘‘outside-in’’ integrin signaling). Since each platelet
has ,80,000 copies of integrin aIIbb3 on its surface [8], very large
aggregates of platelets can rapidly assemble at the site of platelet
activation. A cross-linked fibrin clot ultimately stabilizes the
growing platelet aggregate.
Detailed molecular, cellular, animal and human studies have
provided incredible insights into the structure and function of
platelets, both under normal physiologic conditions as well as in a
variety of disease states [5], however, the molecular mechanisms of
integrin activation and the identities of proteins involved in the
signaling pathways leading to a variety of platelet responses in vivo
are yet to be fully characterized. A key first step in mapping out
such interactions is the cataloging of various components that
make up the platelets as well as identification of post-translation-
ally modified proteins, such as the phosphorylated proteins. Since
platelets are readily available, are easily isolated in relatively large
numbers, lack nuclei and genomic DNA, and have a limited RNA
pool, proteomic techniques are ideally suited for the analysis of
platelets. Indeed, several proteomic analysis techniques have taken
a lead in identifying the proteomic content of platelets, as reported
in several exciting publications (reviewed in [9,10]). Despite these
efforts, a number of proteomic components of the human platelets
remain to be identified, especially notable when considering that
the human platelet proteome has been predicted to contain
approx. 2000–3000 unique proteins [11].
The platelet phospho-proteome has also been investigated by a
number of investigators, including studies on platelets in its basal
state as well as upon activation by the platelet agonists
[12,13,14,15,16,17,18]. A recent study by Zahedi et al. cataloging
the platelet phosphoproteins using platelet rich plasma identified
270 phosphorylated proteins in the resting platelets [17].
Researchers have also identified several proteins that change their
phosphorylation state during platelet activation [13,14,15,18,19].
A recurring theme in all platelet proteomics reports is the need
for multiple complementary proteomic profiling techniques and
the analyses of multiple independent samples to obtain a high-
confidence proteomic profile from such a complex cellular system
[20]. Here, we present a comprehensive proteomic profile of
human platelets from ten independent platelet samples using ten
individual proteomic analyses and a total of 140 1D SDS PAGE
gel slices. Additionally, we present phospho-proteomic profile of
platelets using four separate samples and a proteomic profile of the
platelet membrane fractions. In total, we identified 1507 unique
proteins in the human platelets. This is, by far, the largest platelet
proteomic dataset yet assembled from a single set of studies. We
also present a contextual platelet protein-protein interaction (PPI)
network created advanced bioinformatic approaches on this
comprehensive platelet proteomic dataset and. Our analysis shows
that computational models of the platelet interactome represents
an excellent starting point for studying the protein signaling
pathways.
Results and Discussion
Identification of Platelet Proteins using Multiple Samples
The proteomic composition of isolated platelets in a resting state
was obtained via the workflow strategy detailed in Figure 1A. In
order to increase the confidence associated with proteomic
profiling and to catalog a large fraction of platelet proteins, ten
independent platelet samples were analyzed. Additionally, the
platelets were isolated from two different types of sources: from
platelet rich plasma (PRP) that was obtained from a local blood
Figure 1. Schematic workflow of LC-MS/MS based platelet proteomic profiling. A. Workflow used in the proteomic analysis of human
platelets. Isolated platelets were lysed and the extracted proteins were size-fractionated using 1D-SDS PAGE. The coomassie-stained gel lanes were
cut in 14–16 equally sized sections, and in-gel digested with trypsin. Subsequently, extracted peptide mixture from each gel slice was independently
analyzed using LC-MS/MS to obtain a list of unique platelet proteins. B. Workflow used in the phospho-proteomic analysis of platelets. Isolated
platelets were lysed and the extracted total lysate was digested in-solution with trypsin. The trypsinized samples were enriched for phospho-peptides
using an IMAC column and the enriched peptide mixtures were analyzed using LC-MS/MS to obtain a list of unique platelet phospho-proteins.
doi:10.1371/journal.pone.0007627.g001
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Platelets from whole blood were isolated using an optimized
protocol using centrifugal separation in an acid-citrate-dextrose
(ACD) buffer, which uses citrate as an anticoagulant. Purity of the
isolated platelets was assessed by light microscopy and flow
cytometry, which showed that the platelets isolated from whole
blood were devoid of any red blood cells (RBC) or leukocytes. The
presence of WBC/leukocytes was estimated to be ,0.1% of
platelet population (Figure 2A–D).
To verify that the isolated platelets were in the basally resting
state, the cells were analyzed using flow cytometry. Since activated
platelets express P-selectin (CD62P) and CD63 (type III lysosomal
glycoprotein) on the platelet cell surface, fluorescently tagged anti-
P-selectin and anti-CD63 antibodies were used to count activated
platelets [21,22]. These markers were completely absent on the
surface of the freshly isolated platelets (which stained positively for
the known platelet marker CD41), indicating that the isolated
platelets are indeed in the resting state (Figure 2E–F). Further-
more, activation of the isolated platelets with thrombin, a potent
agonist of platelets, showed a clear increase in the percent positive
events (.70%) and .2-fold change in the MFI values for both
markers, with no concomitant change in the isotype control (data
not shown), as expected based on published literature [23].
We found that the conditions of platelet storage and thawing
had a significant effect on Talin stability in human platelets.
Platelet activation is known to leads to a rapid cleavage of signaling
Figure 2. Analysis of platelet quality using light microscopy and flow cytometry. A, B. Light microscopy images of the anti-coagulated
whole blood sample (A) and the isolated platelets (B) at 406magnification. Red blood cells (RBCs) are clearly visible in the anti-coagulated whole
blood samples (A), whereas no detectable RBCs were seen in the isolated platelet samples (B). C–E. Flow cytometric analyses of anti-coagulated whole
blood (C) and the isolated platelets (D, E). Forward- and side-scatter density plots show that RBC/WBC and platelets populations are clearly
distinguishable based on their respective light scatter patterns. E. Flow cytometric analysis of isolated platelets upon staining with anti-CD41a mAb
(filled histogram) as compared to an isotype control (open histogram). F–H. Flow cytometric analyses of the isolated platelets showing that the
platelets are in a quiescent state. The CD41a+ platelets were further analyzed for markers of platelet activation using antibody against CD62P (P-
selectin) (G) or against CD63 (type III lysosomal glycoprotein) (H), both of which showed no increase as compared to an isotype control antibody (F).
The determined percent positive events (Vs isotype control) and MFI are indicated in each histogram.
doi:10.1371/journal.pone.0007627.g002
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stored as platelet pellets (no ACD buffer), after isolation using the
ACD buffer, showed a dramatic loss of full-length Talin upon
thawing/lysis in the presence of SDS-containing lysis buffer
(Figure 3). The loss of full-length Talin was rapid and was readily
detectable in the coomassie stained SDS PAGE gel (Figure 3A).
We validated the degradation of Talin in isolated platelets by
running the platelet lysates on 1D SDS PAGE followed by
immunoblotting with two different anti-Talin antibodies
(Figure 3B–C). Unexpectedly, western blotting with the anti-Talin
antibody 8D4 showed the presence of a ,37 kDa (Figure 3B),
which seems to be slightly smaller than the ,47 kDa N-terminal
fragment generated as a result of the Talin cleavage by calpain
upon platelet activation [26,27]. Additionally, the mAb 8D4 has
been shown to not recognize the calpain-cleaved 47 kDa N-
terminal fragment of Talin, as the mAb 8D4 epitope lies in the
Talin rod region (residues 482–636) [27]. It also suggests that this
,37 kDa fragment retains at least part of the Talin sequence in
the region 482–636. This is confirmed by the fact that the anti-
Talin C-terminal antibody C-20 did not detect this smaller
,37 kDa fragment, even though it showed a reduction in the total
size of Talin in these platelet samples (Figure 3C). Future work will
determine the identity and the significance of this novel fragment
of Talin. Platelets also express very high levels of the integrin
aIIbb3 and actin. 1D-SDS PAGE followed by immunoblotting
with mAbs against the integrin b3o rb-actin showed no
degradation of these proteins (Figure 3D–E), suggesting that the
Talin was selectively cleaved during the thawing/lysis of stored
platelet pellets.
In order to limit protein degradation, the isolated platelets were
stored at 280uC as a suspension in the citrate buffer, rather than
as pellets. Analysis of the protein lysate using 1D SDS PAGE
showed very similar protein expression pattern in all ten platelet
samples upon staining with coomassie blue (Figure 4A) and no loss
of the full-length Talin band (Figure 4B–C) as compared to the
selective Talin degradation seen earlier. Western blot analysis of
five platelet samples obtained from fresh whole blood and five
platelet samples obtained from PRP with the C-terminal anti-
Figure 3. Platelets stored without citrate buffer show Talin degradation upon thawing. A. Coomassie stained 4–12% Bis-Tris SDS-PAGE gel
shows selective degradation of Talin in lysates from platelet pellets stored in the absence of citrate buffer (Lane 3) Vs no degradation in the presence
of citrate (Lane 2). B. Immuno-blotting with anti-Talin antibody against the Talin N-terminal rod region (antibody 8D4, [27]) shows that Talin is
degraded to smaller fragments in three independent platelet samples stored in the absence of citrate buffer (Lanes 4–6) as compared to three
independent platelet samples stored in the presence of citrate (lanes 1–3). Notice the slight reduction in the MW of full-length Talin band in lanes 4–6
as well as the presence of ,37 kDa fragments in lanes 4–6. C. Similarly, immuno-blotting with anti-Talin antibody against the Talin C-terminal region
(antibody C20) also shows that Talin is degraded to a smaller MW species in two independent platelet samples stored in the absence of citrate buffer
(Lanes 3–4) as compared to two independent platelet samples stored in the presence of citrate (lanes 1–2). Protein MW markers are as labeled. D.
Immuno-blotting with the anti-integrin b3 mAb shows no degradation of integrin b3 upon thawing of stored platelet pellets. Platelet lysates from
three independent platelet samples stored either in the presence of citrate (lanes 1–3) or absence of citrate (lanes 4–6) were thawed and analyzed by
4–12% Bis-Tris 1D SDS PAGE followed by western blotting. Protein MW markers are as labeled. E. Immuno-blotting with the anti-b-actin mAb shows
no b-actin degradation upon thawing of stored platelet pellets. Platelet lysates from three independent platelet samples stored either in the presence
of citrate (lanes 1–3) or absence of citrate (lanes 4–6) were thawed and analyzed by 4–12% Bis-Tris 1D SDS PAGE followed by western blotting.
Protein MW markers are as labeled.
doi:10.1371/journal.pone.0007627.g003
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suggesting that our platelet isolation and storage protocol
preserved the platelet proteomic integrity.
Using the refined preparation and storage protocols, a total of
1451 unique proteins were unambiguously identified in resting
platelets and cataloged according to the appropriate refseq IDs (a
complete list of all identified proteins is shown in Table S1). Figure
S1 shows an example MS/MS spectrum of MH
+ ion of a peptide
from integrin aIIb3, identifying it in the mixture. A complete list of
all identified peptides from each of the ten analyses is shown in
Table S2. Approx. 956 proteins were identified based on more
than one peptide hit. As this proteomic profiling methodology is
biased towards the detection of proteins with higher abundance,
not surprisingly, only 919 of identified proteins were found to be
present in more than one sample and, on average, overlap
between the proteomic profile of any two datasets was approxi-
mately 63%, consistent with the other platelet protein studies using
sample replicates [28,29]. When peptide mixtures from a single
sample was analyzed using LC-MS/MS multiple times (.50
individual runs), the overlap between the proteins identified from
different runs of the same sample was also approx. 60% (data not
shown), suggesting that the level of overlapping protein identifi-
cations between two different samples is similar to the level of
overlap obtained when the same sample is analyzed multiple
times. Additionally, only a small fraction of proteins identified here
were highly expressed, as judged by their relative abundance, and
a majority of the protein signatures were from low level expressors.
Furthermore, approximately 500–800 unique proteins were
identified from a single dataset. This suggests that at the current
level of sensitivity, the detection of proteins expressed at low levels
greatly benefits from analyzing a large number of replicates.
Among the identified proteins, the high expressors (based on the
peptide count) include FLNA (Filamin A), TLN (Talin), MYH9
(Myosin, non-muscle), THBS1 (Thrombospondin), ITGA2B
(integrin alphaIIb) and ITGB3 (integrin beta3), all previously
known to be present in the platelets.
A comparison of the comprehensive platelet proteome for
overlap with some of the previously published data from the
platelet proteomic profiling studies showed .75% overlap
between most of the published studies and our dataset (Figure 5)
[30,31,32,33,34,35,36,37], although the overlap between any two
published studies was low (analysis not shown). As a result, we are
confident that the proteins identified in the present study are from
the human platelets. Proteins typically associated with RBCs (such
as a and b globin or spectrin) were not detected, further verifying
that the contamination from these cells in the isolated platelets was
minimal.
Membrane-associated Platelet Proteins
In order to determine the platelet membrane proteomic
content, we purified the platelet membrane associated proteins
from one of the analyzed platelet sample using published protocols
[38]. Figure 6 shows that known membrane-associated platelet
proteins, such as integrin chains aIIb and b3, are selectively
enriched in the isolated membrane fraction (lane 4), as compared
to the low levels of cytosolic actin in this fraction, signifying that
the membrane-fraction isolated here largely retained membranous
proteins while selecting out a majority of the cytosolic proteins. For
the proteomic profiling step, the purified platelet membrane
fraction was pre-fractionated using 1D SDS-PAGE and processed
according to the workflow shown in Figure 1A. A total of 182
unique platelet proteins from 577 unique peptides (from a total of
1089 peptide identifications) were unambiguously identified as
associated with the platelet membrane fraction (as cataloged by
their uniprot IDs). Representative platelet membrane proteins
include well known proteins, such as integrin aIIb3 heterodimer
(ITGA2B and ITB3), GP1B, JAM-A and G6B among others.
Figure S2 shows an example MS/MS spectrum of MH
+ ion of a
peptide from integrin b3, identifying it in the mixture. A complete
list of all identified proteins is shown in Tables S3 and S4.
Comparison with proteins identified using the whole platelets
showed that .90% of the membrane proteins were co-identified
in the whole platelet analyses, suggesting that our use of ten
independent biological samples in the whole platelet proteomics
sufficiently captured a majority of the platelet proteins.
A comparison of this platelet membrane proteome for overlap
with two of the previously published proteomic profiling studies
with the platelet membrane fractions showed that there were
eighty-eight proteins in common between our dataset and that
from Moebius et al. [33], which found 296 unique proteins in the
platelet membranes, and twenty-eight proteins were in common
with the dataset from Senis et al. [37]. Sixty-two proteins were
reported to be common between these two previously published
studies [37].
Figure 4. Talin is protectected from degradation during platelet thawing/lysis when stored in the presence of citrate. A. SDS-PAGE
analysis of ten independent isolated platelet samples. Platelet lysates from five individual platelet samples isolated from fresh whole blood from
healthy subjects (lanes 1–5) and five individual platelets samples obtained from the platelet rich plasma (PRP) (from blood bank) (lanes 6–10) were
analyzed using 4–12% Bis-Tris SDS-PAGE. Images of the coomassie stained gels show that all ten samples have a very similar protein expression
pattern and no noticeable Talin degradation (when compared with lane 3, Figure 3A). Lane M=Protein MW markers. B–C. Western Blots show no
Talin degradation in the presence of citrate in ten platelet samples. Platelet lysates from five individual platelet samples isolated from fresh whole
blood (B) and five individual samples from platelets isolated from PRP (C) were analyzed by 4–12% Bis-Tris SDS-PAGE followed by immuno-blotting
with anti-Talin antibody C-20. All ten samples show a single band for Talin with minimal degradation. Protein MW markers are as labeled.
doi:10.1371/journal.pone.0007627.g004
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The phospho-proteomic profile was determined using four
independent platelet samples. Unlike a recent study using only one
type of the platelet sample [17], we decided to include multiple
samples from two different sources: two platelet samples isolated
from fresh whole blood and two samples from the platelets isolated
from PRP in our analyses. Figure 1B shows a schematic of
immobilized metal affinity column (IMAC) based proteomic
analysis setup used in our studies (reviewed in [39]). Here, we
unambiguously identified a total of 262 unique platelet proteins (as
cataloged by their uniprot IDs) as phosphorylated proteins in the
basal, resting state from 569 unique phospho-peptides (from a total
of 1300 phospho-peptide identifications). A complete list of all
identified phospho-proteins is shown in Table S5. Additionally, as
acidic peptides are also known to co-elute with the phosphopep-
tides from the positively charged IMAC columns [40,41], we also
identified a total of 104 additional unique non-phosphorylated
proteins (based on their uniprot IDs, as shown as a list in Table S6)
from these four peptide mixtures. In total, these combined 366
protein identifications were based on 1089 unique peptide hits
from a total of 3051 peptide hits. Of the 569 unique phospho-
peptide identifications, 488 peptides were identified to be mono-
phosphorylated, 63 doubly phosphorylated and 18 triply phos-
phorylated peptides (Figure 7A). Additionally, analysis of the
phospho-peptides showed that 443 were phosphorylated at the
serine sites (pSer), 100 were phosphorylated at the threonines
(pThr) and 13 were phosphorylated at the tyrosines (pTyr)
(Figure 7B), providing a ratio of approximately 42:1 pSer and
pThr to pTyr in the present study, which is similar to results from
phosphoproteomic studies in other cells [42], but is 2-fold higher
than the report from a recent phospho-proteomic study by Zahedi
et al., which found a higher number of pTyr by focusing on the
pTyr-specific precursor ion-scanning [17]. A comparison with this
platelet phospho-proteome showed that 97 of the phospho-
proteins identified here were also identified in this published
dataset [17].
Next, the site of protein phosphorylation was qualitatively
investigated by analyzing the position of the phosphorylated
residue relative to the total length of the phosho-protein using
.500 identified unique phosphopeptides from our analyses. For
this analysis, we determined the residue number for the
phosphorylated residue (pSer, pThr or pTyr) and divided that
by the total length of the protein to generate it’s fractional
position relative to the length of each protein (where fractional
position value of 0 means that the phosphorylated residue is the
extreme N-terminal residue, and a fractional position value of 1
means that the phosphorylated residue is the extreme C-terminal
residue). We converted the fractional positional value into a
percentage number (by multiplying with 100) and generated a
graph (shown in Figure 7C) displaying each peptide (Y-axis) and
its fractional position (X-axis). The graph shows that a small
majority of phosphorylation sites were present towards the C-
terminal end of the platelet proteins (275 (blue bars) Vs 225 N-
terminal peptides (red bars), Figure 7C). It is conceivable that this
distribution could change with a much more comprehensive
analysis in the future. However, other studies have also reported a
preference for the protein phosphorylation to occur at the C-
terminus [43]. Additionally, a sharp increase in the slope of this
curve near the extreme C-terminus (between 90% and 100%)
suggests that the extreme C-terminus is a slightly preferred
phosphorylation site, similar to previous phosphosite analyses of
liver proteins [43].
Figure 5. Comparison of the list of identified platelet proteins with platelet proteins described in previous studies. A bar-graph
showing overlap between the protein list generated in the current study and the proteins identified in some of the previously published studies
[31,32,33,34,35,36,37]. The percent overlap between the proteins identified in each of the prior studies and the current study is plotted along the y-
axis and the prior studies are shown along the x-axis.
doi:10.1371/journal.pone.0007627.g005
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The phospho-peptide sequences from each of the three
categories (pSer, pThr and pTyr) were analyzed for the presence
or enrichment of any particular sequence motifs [43]. We aligned
the unique peptides in each of the three categories around the
phosphorylated residues and analyzed the sequences using Motif-
X algorithm (http://motif-x.med.harvard.edu) [44]. Aligned
sequences were used to generate peptide sequence representations
as logos using web logo (http://weblogo.berkeley.edu) [45].
Resulting logos are shown in Figure 8A–C. Since there are far
fewer phospho-peptides containing pThr and pTyr as compared
to pSer, no motifs were found for pThr (Figure 8B) and pTyr
(Figure 8C). Some of the over-represented pSer motifs that were
identified include SDxD, SDxE, SxxD, SxxE, SP, PxSP, and RxxS
(Figure 8A).
Using the Phosphomotif finder, we identified potential kinases
associated with some of the identified motifs [46]. We suggest that
motifs SDxD, SDxE and SxxD/E are associated with casein kinase
II; SP and PxSP is associated with GSK3, ERK1, ERK2 and
RxxS is associated with the kinases such as Protein Kinase A
(PKA), Calmodulin (CaM) Kinase family and Akt.
The di- and tri-phosphorylated peptide sequences were
manually aligned to identify any motifs represented in the di-
and tri-phosphorylated phospho-peptides in our dataset. As the
number of these multi-phosphorylated peptides is low, we did not
perform any statistical analysis on the over-representation of any
of the motifs in our dataset. The manually aligned sequences were
converted into logo representations using weblogo and the results
are shown in Figure 8D–F, which indicates that di-phosphorylated
peptides contain a varying number of intervening residues
(anywhere from 0 to 5 amino acids) in between the two
phosphorylated Ser/Thr residues (Figure 8D). The composite
alignment of di-phosphorylated peptides (Figure 8E) shows that
the +3 and the +1 positions relative to the first phospho-site are the
most preferred second-phosphorylation sites. Analysis of tri-
phosphorylated peptides shows that they also contain a varying
number of intervening residues (anywhere from 0 to 8 amino
acids) in between the three phosphorylated Ser/Thr residues, as
shown in a composite alignment of the tri-phosphorylated peptides
(Figure 8F). Additionally, it shows that the +3 and +6 positions in
the sequence relative to the first phospho-site are the most
preferred multi-phosphorylation sites. Finally, we also found a
number of di- and tri-phosphorylated peptides to be represented as
mono-phosphorylated peptides in the database, where only one of
the two sites in the peptide sequence was phosphorylated. This is
not unexpected, as protein phosphorylation typically involves a
sequential mono-phosphorylation reaction. It is also known that
many mono-phosphorylated sequences can enhance the rate of
subsequent second/multi-phosphorylation of the same protein.
Classification of Identified Platelet Proteins
We combined all of the identified proteins from the three
different types of proteomic analyses on multiple independent
platelet samples and converted the refseq IDs to Uniprot IDs to
obtain a comprehensive list of proteins from our study, resulting in
a list of 1507 unique proteins in the resting platelets (as identified
by their Uniprot IDs), shown in the Table S7. Using the Ingenuity
Pathway Analysis (IPA [47]) software the sub-cellular localization
of the identified proteins was identified. We find that 54% (,813
proteins) are localized in the cell cytoplasm, 12% in the
membrane, 7% are secreted (likely from various intra-cellular
granules), 13% show mapping as nuclear proteins and the
remaining 14% did not have any sub-cellular localization
information available in this database (Figure 9). The analysis
also revealed the presence of 81 protein kinases, 33 protein
phosphatases, 55 peptidases and 369 other enzymes. Functional
analysis of the proteins using IPA software (Figure S3) showed that
the over-represented cellular and biological functions associated
with this set of proteins include cell movement, inflammatory and
immune response and hematological function–all the functions
that are commonly associated with the platelets. Not surprisingly,
IPA analysis also showed that the disease pathways over-
represented in this protein set include hematological and
inflammatory diseases (Figure S4).
Protein-protein Interaction Network of Platelet Proteins
Placing proteins in computational interaction networks has been
successfully used to not only identify biological function of
individual proteins, but has also provided new insights into the
functional networks of proteins in a cellular context (see
[48,49,50,51,52,53]). Recently, PPI networks have been applied
to the available platelet data [11]. In order to gain deeper
biological insights from this platelet proteomic dataset, we
generated a comprehensive platelet protein-protein interaction
(PPI) network using our proteomic dataset. First, we determined
Figure 6. 1D SDS-PAGE analysis of purified platelet membrane
fraction. Platelet membrane was prepared as described in text. All
fractions were analyzed using a 4–12% Tris-acetate pre-cast SDS-PAGE
gel. Image of the coomassie stained gel shows that membrane fraction
is highly enriched for membrane-associated proteins, such as integrin
aIIb and b3 chains (arrows). Lane 1=Molecular Weight markers
(SeeBlue Plus2 from Invitrogen), Lane 2=total platelet lysate, Lane
3=cytoplasmic fraction after fractionation of platelet lysate on a 40%
sucrose gradient, Lane 4=extracted membrane fraction, Lane 5=in-
soluble pellet after membrane fraction extraction.
doi:10.1371/journal.pone.0007627.g006
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using the PPI data from the publicly available HPRD database, an
aggregator of many different sources of experimentally observed
direct protein-protein interaction data [54]. This yielded a base
network of 2194 interactions among the 870 of all 1507 identified
proteins (remaining proteins showed no interactions in HPRD
database). We visualized the PPI network using Cytoscape [55].
This base network is shown in Figure S5. Each non-phosphory-
lated protein is represented by a solid gray colored dot (node). The
phosphorylated proteins identified in this study are shown as red
dots. Interaction between two proteins is represented by a line
(edge) connecting two nodes.
Next, we expanded our base PPI network as follows. First, we
added potential new interactions using the phospho-peptides
indentified. Phosphomotif finder database contains a literature
curated mapping of the kinase binding and phosphorylation motifs
[46]. Using the kinases present in our dataset and the
Phosphomotif finder, we defined the likely phospho-peptide
sequences that the kinases in our dataset would phosphorylate.
We added these additional 297 predicted interactions to our PPI
network. Second, as a goal of the present study is to create a
computational framework (based on the proteomics data) for
gaining deeper insights into integrin signaling pathways and be
able to make testable predictions about them, we incorporated
interactions from a recently described integrin adhesome network
into our dataset [56]. The adhesome components are highly
conserved among a variety of cell types and provide a
comprehensive dataset for understanding integrin-related path-
ways in the PPI networks. The adhesome network contains 156
protein components and 690 interactions among these compo-
nents, derived from published experimental studies. Inclusion of
these two sets of data into our PPI network resulted in a platelet
PPI network consisting of 1034 protein components and 2993
interactions among them. Finally, in order to obtain insights into
the functional groups present in this network, we used the
MCODE plugin [57] to cluster the PPI network. The resulting
network is shown in Figure 10, where each protein is presented as
a colored node (the phospho-proteins are shown as black colored
nodes) and a blue colored edge represents interaction between any
two proteins. Remarkably, this PPI network showed enrichment of
several related proteins into expected functional groups. Proteins
constituting a cluster are represented by a single color (except for
phospho-proteins, which are black). This clustering of related
proteins into expected functional groups was achieved in the
absence of any other applied constrains (such as the use of Gene
Ontologies to bring together related groups of proteins). However,
analysis of the PPI network showed that the average shortest path
length (i.e.; average length of a shortest path between a given node
(protein) and any other node in the network) is only 3.5. The
network analysis also showed that the network is highly connected
and that the proteins have, on average, 5.8 neighbors. Such short
path lengths and high connectivity make it difficult to identify
signaling pathways using these kinds of PPI networks.
Generation of a Directed Graph using phospho-
proteome data: Insights into Integrin Signaling
Changes in the platelet functional state are known to
dynamically regulate protein-protein interactions, thereby chang-
ing the signaling pathways and thus regulating platelet function.
For example, activation of integrin aIIbb3 leads to a stable
adhesion of circulating platelets and further changes in the cell
shape. However, typical PPI networks, as we developed in
Figure 10, do not provide any detailed insights into the signaling
pathways. One reason is that the available databases, such as
HPRD, contain protein-protein interaction information from a
variety of cell types and under a variety of conditions. However,
protein-protein interactions are highly dynamic and change based
on the local context within a cell. In order to address this weakness
in the current PPI networks, we developed a novel method by
incorporating additional available ‘‘contextual’’ information. This
contextual information came in the form of mappings for a) the
phospho-proteins (the phospho-proteins identified in our analyses
above were labeled as such in the PPI network), b) the protein
Figure 7. Analysis of Protein phosphorylation-site distribution. A. A pie chart showing the distribution of the three types of phosphorylation
sites, pSer (pS), pThr (pT) and pTyr pY), across all of the unique phospho-peptides identified in this study. B. A pie chart showing the distribution of
number of phospho-sites per identified peptide across all of the unique phospho-peptides identified in this study. C. Distribution of phospho-sites
relative to protein length. A graph showing the position of the identified phosphorylated residue relative to the total protein length as a percentage
for all of the identified phospho-proteins. Each phospho-peptide sequence was queried against its mapped protein sequence from the Uniprot
database and the position of the phosphorylated residue in the sequence was determined. Relative position percentage of each phospho-site was
calculated by dividing the determined position number for the phosphorylated residue with the total length of the mapped protein and multiplying
the resulting fraction by 100. The relative position percentage of each peptide was graphed using a horizontal bar graph, with the calculated relative
position percentage values on the x-axis and each of the phospho-peptide on the y-axis. Proteins where the phosho-site is in the N-terminal half (less
than 50% relative position, x-axis) are colored red and the rest are colored blue.
doi:10.1371/journal.pone.0007627.g007
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PLoS ONE | www.plosone.org 8 October 2009 | Volume 4 | Issue 10 | e7627Figure 8. Computational identification of sequence motifs in phospho-peptides. A–C. Phospho-peptides containing single phosphorylation
at (A)Ser, (B)Thror (C)Tyr were analyzedfor the presence of sequencemotifs using the Motif-X algorithm[44] as described in theMaterials and Methods
section. Sequence logos for Motif-X aligned peptide sequences were generated using weblogo [45] and are shown above for each of the three types of
phospho-peptides identified in this study. D–F. Identification of sequence motifs in multiply phosphorylated peptides. Phospho-peptides containing di-
and tri-phospho residues were analyzed for the presence of sequence motifs by manual alignment as described in the Materials and Methods section.
Sequence logos for the aligned peptide sequences were generated using weblogo [45] and are shown above for the (D) di-phosphopeptides with
varying number of residues in between the two phosphor-sites. A composite sequence logo using all of the (E) the di-phosphopeptides and (F) the tri-
phosphopeptides shows the relative preference for the second and the third phosphorylation site in these multi-phosphorylated peptides.
doi:10.1371/journal.pone.0007627.g008
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protein phosphatases identified were also labeled as such). This
‘‘contextual’’ information was used to convert some of the non-
directional edges into directional edges as follows: we converted a
non-directional edge between two protein partners in our PPI
network into a directed edge from a kinase to a phospho-protein, if
the linkage satisfied the condition that the identified kinase is likely
to phosphorylate the phospho-protein at the identified phospho-
peptide sequence as predicted by Phosphomotif finder [46].
Additionally, if the phospho-protein was connected with a protein
phosphatase, we converted that edge into a directed edge between
the phospho-protein and the phosphatase, as the currently
available algorithms for predicting the consensus protein phos-
phatase site in a phospho-protein are quite weak (which is a
shortcoming of this and other similar studies). As a result, we
established a limited directionality in our PPI network to develop
this contextual PPI network, which can be utilized in identifying
signaling pathways in the future.
Finally, we used the newly developed contextual PPI network to
determine if it would provide any signaling insights using purely
computational means. We focused on integrin b3 (ITB3), the beta
chain of the integrin aIIbb3 heterodimer and recapitulated a
known pathway as a model. ITB3 was identified as a phospho-
protein in our phospho-proteomic analyses and the sequence of
the phospho-peptides is shown in Figure 11A. Our PPI network
showed that there were six potential protein kinases that were
directly connected to this phospho-protein (Figure 11B). However,
cross-mapping of these six potential kinases and the sequence of
the ITB3 phospho-peptide using Phosphomotif finder [46]
suggested that only one, PDPK1 (3-phosphoinositide dependent
protein kinase-1), was capable of phosphorylating ITB3 at the
threonine residues in this sequence. Indeed, literature mining
confirmed that PDPK1 phosphorylates ITB3 and is responsible for
maintaining this integrin in the inactive state [58,59,60,61].
Furthermore, HPRD database shows that ITB3 is tyrosine
phosphorylated at Y759, upon outside-in integrin activation, by
SRC kinase [61,62]. This lead to a computational recapitulation of
a known mechanism for integrin ITB3 activation and signaling
(which has been previously described using in vitro methods
[58,59,60,61,62,63,64]) as follows: Threonine phosphorylation of
ITB3 maintains it in the inactive state in resting platelets.
Dephosphorylation, likely by protein phosphatase PP1A and/or
PP2A leads to generation of non-phosphorylated ITB3
(Figure 11C–D) [63]. This non-phosphorylated (but not the
threonine phosphorylated) ITB3 is subsequently phosphorylated at
a tyrosine residue by the protein tyrosine kinase SRC [62]. SRC
phosphorylation of ITB3 leads to binding of adaptor SHC and
others [64], outside-in signaling by the integrin and initiation/
augmentation of platelet activation [62,64]. Thus, this simplifica-
tion of platelet PPI network by incorporation of available
contextual information rapidly confirmed an integrin activation
and signaling pathway and, therefore, can be used to provide
insights into this and other pathways. We believe that this model of
contextual PPI network will serve as a new model for improving
the biological significance and the predictive powers of the current
PPI networks and may provide insights into their dynamics.
In summary, by using a number of individual platelet samples
and three different proteomic profiling techniques, we have
identified 1507 unique proteins as constituents of human platelets
in its basal, resting state. The platelet proteomic dataset includes
190 membrane-associated proteins and 262 phospho-proteins.
The identified platelet proteins were used to generate a
comprehensive platelet protein-protein interaction network that
computationally recapitulated known integrin pathways and can
be used as a model for studying the dynamics of PPI and protein
signaling pathways in human platelets and other cells in the future.
Materials and Methods
Reagents and antibodies
All biochemical reagents were from Sigma (St. Louis, MO),
Invitrogen (San Diego, CA) or Fisher Scientific, unless otherwise
specified. Antibodies were purchased from commercial sources as
indicated: the anti-Talin mAb 8D4 was from Sigma (St. Louis,
MO), the goat anti-Talin antibody (C20), rabbit anti integrin b3
(H-96, sc-14009), goat anti-rabbit-HRP and anti-goat-HRP were
from SantaCruz Bio (Santa Cruz, CA), the rabbit anti-mouse-
HRP and anti-b-actin (N350) were from Amersham (Piscataway,
NJ), and anti-CD41a-PE (557297), anti-CD62P-FITC (550866),
anti-CD63-FITC (550759), anti-glycophorin A-FITC (559943)
and the IgG1 isotype control mAb (557273) were from BD
Pharmingen (San Diego, CA).
Platelet isolation
Fresh whole blood was collected from five healthy subjects under
an IRB approved protocol. Five independent platelet rich plasma
(PRP) samples (day 6) were obtained from a local blood bank. The
platelets were isolated from each of these samples with a slight
modification of the published protocols [31]. Briefly, 10 mL human
whole blood was collected by venipuncture and mixed immediately
with 1/9
th volume of acid-citrate-dextrose solution (ACD, 75 mM
trisodium citrate, 124 mM dextrose, and 38 mM citric acid). Room
temperature centrifugation of the above citrated blood at 2006g for
10 min wasused to removeredbloodcells(RBC) and leukocytesand
to obtain platelet rich suspension. In order to avoid any
contamination from the buffy coat, ,0.5 mL of the platelet-rich
suspension above the buffy coat layer was left behind in the
centrifugation tube. Any residual RBC and leukocytes wereremoved
from the platelet-rich suspension and the PRP byre-centrifugation at
2006g for 10 min at room temperature. The platelets were pelleted
by room temperature centrifugation of this suspension at 12006g for
Figure 9. Sub-cellular localization of the identified platelet
proteins. The complete list of 1507 identified platelet proteins from
this study was used in determining the subcellular localization of the
identified proteins using the IPA software ([47], see text). This figure
shows the results for each of the identified categories as a pie chart.
Each category and the relative percentage of total proteins present in
that category is shown in the graph.
doi:10.1371/journal.pone.0007627.g009
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citrate wash buffer (11 mM glucose, 128 mM NaCl, 4.3 mM
NaH2PO4, 7.5 mM Na2HPO4, 4.8 mM sodium citrate, 2.4 mM
citric acid, pH 6.5) and pelleted by centrifugation at 12006g for
10 min at room temperature to isolate the pure platelets as pellets.
Some of the platelet samples were stored as platelet pellets at this
stage. As described in the text of the article, thawing/lysis of these
platelet pellets showed a selective cleavage of Talin in these samples.
For the proteomic profiling studies described in the text, the platelet
pellets were re-suspended in 0.3 mL of the citrate wash buffer
immediately following the centrifugation step with the citrate wash
buffer and were stored in 75 mL aliquots at 280uC. For the
proteomic profiling studies,each platelet aliquot (75 mL) was lysed by
adding25 mLof4XSDS-PAGEloadingbuffer(2%SDSin100 mM
ammonium bicarbonate, 10 mMDTT, pH 8.6) and boiling at 95uC
for 5 min. Lysed platelet samples were kept frozen at 280uCu n t i l
proteomic profiling by 1D SDS-PAGE and LC-MS/MS.
Isolation of platelet membrane-associated proteins
Membrane-associated proteins were obtained from isolated
platelets using a slight modification of published protocols [38].
Briefly, isolated platelets were resuspended in 9 mL TBS buffer
(25 mM Tris.Cl pH 7.2, 150 mM NaCl) containing protease
inhibitors (5 mM diisopropyl fluorophosphate (DFP), 25 uM
Leupeptin, 5 uM Pepstatin and 10 uM Phosphoramidon). The
platelet suspension was homogenized, on ice, by 10 strokes of a
Douncehomogenizer and kept on ice foran additional 10 min. The
platelet membranes were disrupted by passing through a French
press at 1000 psi. Lysate was carefully layered on top of a 40%
sucrose (in TBS) cushion (3 mL) and centrifuged at 26,000 rpm for
4 h at 4uC in ultracentrifuge using SW41 rotor (Beckman-Coulter,
CA). The top-layer above the interface was saved as the cytoplasmic
fraction. The crude membrane fraction was collected from the
gradientinterface.Membrane fractionwaswashed byre-suspension
in 10 mL Tris buffer (20 mM Tris.Cl pH 7.2, 1 mM CaCl2 and
0.5 mM MgCl2) containing protease inhibitors and was subse-
quently centrifuged at 26,000 rpm for 1 h at 4uC. The supernatant
was discarded and the pelleted membrane fraction was re-
suspended in n-octyl-beta-D-glucopyranoside (NOG, from Ana-
trace, OH)/Guanidinium buffer (8 M Guanidinium.HCl, 100 mM
ammonium bicarbonate, 2% NOG, 10 mM DTT, pH 8.6) to
extract membrane associated proteins. Any insoluble membranous
debris was removed by centrifugation at 26,000 rpm for 1 h at 4uC
and the membrane-associated proteins were collected from the
supernatant. Subsequently, Guanidinium.HCl was removed from
this protein solution by dialysis and the membrane-associate
proteins were analyzed by 1D SDS PAGE followed by LC-MS/
MS as described below.
Figure 10. Platelet Protein-Protein Interaction (PPI) network. A graph showing the platelet PPI network. Literature curated interactions
between any set of two platelet were identified using the publicly available HPRD database [54] and graphed to generate a PPI network. Each platelet
protein is shown as a colored dot and interaction between any two proteins is shown as a blue colored edge. Black dots represent phospho-proteins
identified in this study. The PPI network was visualized using Cytoscape [55] and proteins showing high degree of interactions were clustered using
the MCODE plugin [57]. Protein nodes that were found to be clustered based on degree of interactions are grouped and are shown in a single color.
Biological function of protein clusters was determined using Uniprot database and is shown above.
doi:10.1371/journal.pone.0007627.g010
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(A) All proteomic and phospho-proteomic profiling assays and
peptide identifications were performed at the Proteomics Core of
the Harvard Partners Center for Genetics and Genomics
(HPCGG). A. Protein pre-fractionation and digestion. Platelet proteins
were separated in 1D using 4–12% SDS-PAGE precast gels
(Invitrogen, CA) at 150 V and stained with Coomassie blue
according to standard protocols. For an extensive mass spectro-
metric interrogation of the platelet proteome, the gel lane
containing the sample was cut into 12–14 equally sized sections
irrespective of staining intensity and in-gel digestion of the bands
was performed according to published protocols [34,65]. Briefly,
gels were imaged with a Kodak DC280 Digital Camera fitted with
a +10 Macro lens. Images were processed using Adobe Photoshop
and printed out. Gels were cut with a clean razor blade into 12–14
gel slices each while marking positions of the cuts for each slice.
Gel sections were placed into 2 mL Axygen tubes and destained
with two washes of aqueous solution containing 50% methanol
Figure 11. Contextual PPI network based computational recapitulation of integrin activation pathway. A. A cartoon representation of
the domain structure of integrin beta3 chain, with majority of the domains labeled. Phoshorylated threonine residues identified in the current study
are shown at the bottom. B. Names of six kinases that were found to show a direct interaction with ITB3 in the platelet PPI network. C. Signaling
pathways showing integrin ITA2B and ITB3 and selected interacting protein kinases and phosphatases that are present in our platelet PPI network.
ITB3 interacts with ITA2B (a-chain of the integrin heterodimer) and is found phosphorylated at threonine residues T753 and T755 in the resting
platelets. Phosphomotif finder [46] mapping suggests that PDPK1 (3-phosphoinositide dependent protein kinase-1) is the likely kinase that
phosphorylates ITB3 at this site. Literature mining also suggests that PDPK1 interacting protein 14-3-3 inhibits this kinase [58,59,60,61]. Threonine
phosphorylation of ITB3 maintains it in the inactive state. ITA2B interacting protein phosphatase PP1A and/or PP2A likely dephosphorylates this site
and leads to generation of non-phosphorylated ITB3 [63]. D. In activated platelets, the non-phosphorylated ITB3 is a substrate for SRC kinase. HPRD
database shows that ITB3 can be phosphorylated at residue Y759 [61,62]. SRC phosphorylation of ITB3 leads to binding of other proteins, such as SHC
and others [64], outside-in signaling by the integrin and initiation/augmentation of platelet activation [62,64].
doi:10.1371/journal.pone.0007627.g011
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removed and the gel pieces were rinsed with ammonium
bicarbonate. The gel slices were next reduced and alkylated using
10 mM dithiothreitol (DTT) and 55 mM iodoacetamide, respec-
tively, for 1 h at room temperature in the dark. The gel pieces
were then rinsed with three alternating washes of ammonium
bicarbonate and acetonitrile. The final acetonitrile wash was
removed just prior to digestion and the gel slices dried for 30 min
in a speed vac (Thermo Savant SC280). The tubes containing the
dried gel pieces were placed on ice and 25 mL of sequencing grade
porcine trypsin (Promega, Madison, WI) at a concentration of
5.5 mg/mL in 50 mM ammonium bicarbonate was added to each
sample. The gel pieces were allowed to swell for 15 minutes on ice
after which excess trypsin solution was removed and an additional
25 mL of 50 mM ammonium bicarbonate was added to each tube.
The tubes were then capped and incubated for 16 h at 37uC.
Peptide were extracted with 2 washes of 75 mLo f5 0 m M
ammonium bicarbonate and two washes of 75 mL of aqueous
solution containing 50% acetonitrile and 0.1% formic acid. All
extracts were frozen at 280uC and lyophilized to dryness in a
speed vac at ,10mTorr. The lyophilate was re-dissolved in 24 mL
of aqueous solution containing 5% acetonitrile and 0.1% formic
acid for LC-MS/MS mass spectrometry analysis. A total of 152 gel
slices were used in this study. (B) Mass spectrometry using
nanospray LC-MS/MS. Trypsin-treated samples were analyzed
using a LCQ DECA XP plus ProteomeX workstation. 10 mLo f
each reconstituted sample was injected with a Famos Autosampler
while the separation was done on a 75 mm i.d.618 cm column
packed with C18 media running at a 235 nL a minute flow rate
provided from a Surveyor MS pump with a flow splitter with a
gradient of 5–60% water 0.1% formic acid, acetonitrile 0.1%
formic acid over the course of 180 min (4 h run). In between each
set of samples two standards of a 5 Angio mix peptides (Michrom
Bioresources, Inc., Auburn, CA) were run to ascertain column
performance, and observe any potential carryover that might have
occurred. The LCQ was run in a top five configuration, with one
MS scans and five MS/MS scans. Dynamic exclusion was set to 1
with a limit of 30 seconds. (C) Peptide identifications. Peptide
identifications (ID’s) were made using the TurboSequest program
through the Bioworks Browser 3.2 (Thermo Electron, San Jose,
CA). Sequential database searches were made using the RefSeq
Human Protein Database from NCBI (National Center for
Biotechnology Information, Bethesda, MD; release 7) [66] using
differential carbamidomethyl modified cysteines and oxidized
methionines, followed by further searches using differential
modifications. Secondary searches were performed with Sequest
using RefSeq Human Gnomon predicted protein database and a
reversed database generated using the db_reverse Perl script [67],
to minimize false sequence detections (to ,5%). In this fashion
known and theoretical protein hits can be found without
compromising the statistical relevance of all the data. Peptide
score cutoff values were chosen at Xcorr (cross correlation) of 1.8
for singly charged ions, 2.5 for doubly charged ions, and 3.0 for
triply charged ions, along with deltaCN (delta correlation) values
of 0.1, and RSP (Ranking of the primary score) values of 1.
Additionally, a restriction that all peptides must be fully tryptic was
placed on the data. The cross correlation values chosen for each
peptide assured a high confidence match for the different charge
states, while the deltaCN cutoff insured the uniqueness of the
peptide hit. The RSP value of 1 ensured that the peptide matched
the top hit in the preliminary scoring and that the .dta peptide
fragment file only matched to one protein hit. (D) Phospho-
proteomic profiling of platelets. (A) Protein digestion. Platelet
samples were prepared for phospho-proteomic profiling using a
slight modification of published protocols [43]. Platelets were lysed
in an aqueous solution containing 8 M guanidinium hydrochloride
(GuHCl), 100 mM ammonium bicarbonate, 10 mM DTT and
5% n-propanol. The protein mixture was reduced and alkylated
using 10 mM DTT and 45 mM iodoacetamide, respectively, for
1 h at room temperature in the dark. The solution was diluted 8-
fold into an aqueous buffer with a final concentration of 25 mM
Tris-HCl, pH 8.3 and 1 mM CaCl2 and digested with 5.5 mg/mL
of sequencing-grade modified trypsin (Promega, Madison, WI)
(enzyme/substrate ratio of 1:250) for 16 h at 37uC. Digestion
reaction was stopped by the addition of TFA to 0.4%. Peptides
were desalted on a C18 Sep-Pak cartridge (Waters, Milford, MA)
and the eluate was dried in a Speedvac and stored at 280uC. (B)
Enrichment of phospho-peptides using IMAC. Platelet peptide
mixtures were enriched for phospho-peptides using a slight
modification of published protocols [43]. The lyophilysed platelet
peptide mixture was re-dissolved in 100 mL of aqueous wash buffer
(AWB) containing 30% acetonitrile and 250 mM acetic acid.
15 mL Fe(III)-loaded IMAC slurry (50% beads) (Phos-Select iron
affinity gel, SIGMA), pre-equilibrated with the same buffer, was
added to the peptide solution. Next, the samples were incubated
with vigorous shaking for 90 min at room temperature. Subse-
quently, the IMAC beads were washed three times with 350 mLo f
AWB. Peptides were eluted from the IMAC beads twice by adding
20 mL of elution buffer (50 mM KH2PO4/NH3, pH 10.0) to the
beads and incubating at room temperature for 15 min. Eluates
were acidified with 20 mL of 5% formic acid, dried in a Speedvac,
desalted using stage-tips and stored at 280uC. (C) Mass
spectrometry using nanospray LC-MS/MS. IMAC-isolated sam-
ples were analyzed using a LTQ-FT ion-trap mass-spectrometer
(Thermo Electron, San Jose, CA). The lyophilate from IMAC-
columns was re-dissolved in 24 mL of aqueous solution containing
5% acetonitrile and 0.1% formic acid. 10 mL of each reconstituted
sample was injected with a Famos Autosampler while the
separation was done on a 75 mm i.d.618 cm column packed with
C18 resin (Michrom Bioresources, Inc., Auburn, CA) running at a
235 nL a minute flow rate provided from a Surveyor MS pump
with a flow splitter with a gradient of 5–60% water 0.1% formic
acid, acetonitrile 0.1% formic acid over the course of 100 min
with a total run length of 150 min. The LTQ-FT was run in a top
four configuration at 200 K resolution. For each cycle, one full
MS full scan - (m/z 350–1800) was acquired in the ion-trap (MS
scan), followed by MS/MS scans (MS
2 scans) - on the four most
abundant precursor ions. Dynamic exclusion was set to 1 with a
limit of 30 seconds. Charge-state screening was used to reject
singly charged ions. A third scan (MS
3 scan) was automatically
acquired for the most intense peak in the MS
2 spectrum with a
neutral loss trigger set at masses 98, 49 and 32.7 Da. (D) Phospho-
peptide identifications. First, full scan data was analyzed using
DeCyder MS software. Phospho-peptide identifications and
phosphorylation site localizations were made usingthe TurboSe-
quest program through the Bioworks Browser 3.2 (Thermo
Electron, San Jose, CA) in a manner similar to the methods
described for peptide IDs above.
Consensus phospho-motif discovery
Consensus peptide sequence motifs near phosphorylation sites
were determined as described in the literature using the Motif-X
program (http://motif-x.med.harvard.edu) [45]. For pSer, the
peptide sequences were restricted to 9 amino acids in length for
alignment. The significance threshold was set to p,10
23. The
minimum number of motif occurrences was set to 20. For pThr
and pTyr, the peptide sequences were extended to 11 amino acids
and the significance threshold was set to p,10
23. The minimum
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Sequence logos were generated with Weblogo at http://weblogo.
berkeley.edu [45]. The di- and tri-phosphopeptide sequences were
aligned manually and their logos were generated as described
above.
Flow cytometry based analysis of platelets
Flow cytometry was performed on a Becton Dickinson
FACScan and analyzed with Cellquest software (Becton Dick-
inson, Palo Alto, CA) according to published protocols [21,22].
Briefly, the platelet and RBC/erythrocyte populations in purified
platelets or anti-coagulated whole blood were identified by their
forward and side light scatter characteristics and a gate placed
around each of the two cell types. The two samples were also
stained with the phycoerythrin (PE)-conjugated anti-CD41a
(GPIIb) and fluorescein isothiocyanate (FITC)-anti-CD235a
(Glycophorin A) to verify placement of the correct forward and
side scatter of platelets and RBCs/erythrocytes, respectively. Both
antibodies, and their corresponding isotype controls were from BD
Biosciences (San Diego, CA). Resting platelets and platelets
activated by thrombin (from BD Biosciences) treatment were
analyzed by staining with anti-CD41a-PE and with either anti-
CD62P-FITC or anti-CD63-FITC mAbs to confirm whether the
platelets are in the resting or an activated state.
Light microscopy
Anticoagulated whole blood and washed platelets were fixed
with 2% formaldehyde. A drop of diluted fixed samples was
applied to a regular glass slide and incubated for 10 minutes under
humidified condition. After mounting cover-slips, light micro-
graphs were taken at 406 magnification (Nikon, Eclipse E800)
using CCD camera (Hamamatsu, model 742-95). A minimum of 8
random images were taken per slide.
Western blot analyses
Platelet samples were separated by SDS-PAGE using a 4–12%
gradient Bis-Tris gels (Invitrogen, CA USA) under reducing
conditions and electroblotted onto PVDF membranes (Bio-Rad
Laboratories, CA). After blocking with 10% nonfat milk in 25 mM
Tris-HCl, pH 7.4, 137 mM NaCl, 2.7 mM KCl (TBS, Boston
Bioproducts, MA), the membrane was incubated with a primary
antibody (as described in Reagents and antibodies section). Detection
of proteins was performed using an appropriate horseradish
peroxidase (HRP) linked secondary antibody and SuperSignalH
Chemiluminescent kit (Pierce Chemical Company, Milwaukee,
WI). The luminescent signal was detected using BioMax x-ray
films (Eastman Kodak Company, NY USA).
Supporting Information
Figure S1 An example MS/MS spectrum of MH+ ion of an
identifying peptide from integrin alphaIIb in a platelet lysate. An
MS/MS spectrum recorded at MH+ 2827.05 corresponding to a
peptide from the integrin subunit alphaIIb (R.GAVDIDDNGYP-
DLIVGAYGANQVAVYR.A). Fragment ions of type b and y are
labeled.
Found at: doi:10.1371/journal.pone.0007627.s001 (1.60 MB TIF)
Figure S2 An example MS/MS spectrum of MH+ ion of an
identifying peptide from integrin beta3 in platelet membrane
sample. An MS/MS spectrum recorded at MH+ 1421.58
corresponding to a peptide from the integrin subunit beta3
(R.AKWDTANNPLYK.E). Fragment ions of type b and y are
labeled.
Found at: doi:10.1371/journal.pone.0007627.s002 (1.24 MB TIF)
Figure S3 Cellular and biological functions of the platelet
proteome. A bar graph showing the cellular and biological
functions over-represented in the identified platelet proteome, as
determined by the IPA software. The y-axis shows the -log (p-
value) associated with the predicted functional enrichment.
Found at: doi:10.1371/journal.pone.0007627.s003 (0.33 MB TIF)
Figure S4 Disease pathways represented by the platelet
proteome. A bar graph showing the disease pathways over-
represented in the identified platelet proteome, as determined by
the IPA software. The y-axis shows the -log (p-value) associated
with the predicted pathway enrichment.
Found at: doi:10.1371/journal.pone.0007627.s004 (0.31 MB TIF)
Figure S5 Platelet Protein-Protein Interaction (PPI) network. A
graph showing the platelet PPI network. Literature curated
interactions between any set of two platelet were identified using
the publicly available HPRD database [54] and graphed using
Cytoscape [55] to generate a PPI network. Each platelet protein is
shown as a colored dot and interaction between any two proteins is
shown as a blue colored edge. Red dots represent phospho-
proteins identified in this study and gray dots represent the
remaining non-phosphorylated proteins.
Found at: doi:10.1371/journal.pone.0007627.s005 (5.52 MB TIF)
Table S1 A comprehensive list of identified platelet proteins
(from 10 independent samples). Protein refseq IDs, genbank IDs
and protein names are shown.
Found at: doi:10.1371/journal.pone.0007627.s006 (0.16 MB
PDF)
Table S2 Ten lists of proteins and the identifying peptides from
proteomic profiling of ten individual platelet samples. Protein
identification is based on its refseq ID. Definition of additional
terms is as follows: P (pro) is the protein probability (normalized to
1); P (pep) is the peptide probability (normalized to 1); Sf score is
the quality of the match in a TurboSEQUEST search. The
protein Sf score is the sum of peptide Sf scores for all the peptides
associated with that protein; consensus Score is the quality of the
match in a TurboSEQUEST search.
Found at: doi:10.1371/journal.pone.0007627.s007 (9.66 MB
PDF)
Table S3 A list of all membrane-fraction associated proteins
identified in this study. Protein uniprot name, Gene name,
Uniprot accession number, Protein name, Gene ontology
classification, Predicted sub-cellular localization and Protein family
are shown based on its description in the Uniprot database (www.
uniprot.org).
Found at: doi:10.1371/journal.pone.0007627.s008 (0.13 MB
PDF)
Table S4 A list of 190 unique proteins and the identifying
peptides from proteomic profiling of the platelet membrane
fraction. Protein identification is based on its Refseq ID and the
definition of additional terms is the same as described for Table
S2A.
Found at: doi:10.1371/journal.pone.0007627.s009 (0.19 MB
PDF)
Table S5 A list of 262 unique phosphorylated proteins identified
using four independent samples in this study. Protein uniprot
name, Gene name, Uniprot accession number, Protein name,
Gene ontology classification, Predicted sub-cellular localization
and Protein family are shown based on its descrition in the
Uniprot database (www.uniprot.org).
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PDF)
Table S6 A list of all non-phosphorylated proteins identified
during phospho-proteomic profiling of platelets. Protein uniprot
name, Gene name, Uniprot accession number, Protein name,
Gene ontology classification, Predicted sub-cellular localization
and Protein family are shown based on its descrition in the
Uniprot database (www.uniprot.org).
Found at: doi:10.1371/journal.pone.0007627.s011 (0.09 MB
PDF)
Table S7 A combined list of 1507 platelet proteins identified in
this study. Protein uniprot name, Gene name, Uniprot accession
number, Protein name, Gene ontology classification, Predicted
sub-cellular localization and Protein family are shown based on its
descrition in the Uniprot database (www.uniprot.org). Comments
column describes whether the protein was identified as associated
with the membrane fraction or as a phospho-protein in this study.
Additional columns describe if the protein is known to be
phosphorylated in literature databases. The function column tags
known protein kinases and phosphatases in our dataset.
Found at: doi:10.1371/journal.pone.0007627.s012 (1.13 MB
PDF)
Acknowledgments
We thank David Sarracino and Ken Parker at the Proteomics Core of the
Harvard Partners Center for Genetics and Genomics (HPCGG) for
proteomic profiling, Jun Park, Christine Min and Kyle Robinson for help
with platelet analyses, and Arun Mohanty and Saurabh Anand for platelet
membrane preparations.
Author Contributions
Conceived and designed the experiments: MJZ VG. Performed the
experiments: AHQ DM MHF CJB BK. Analyzed the data: VC SMS MS
DS BK MO MJZ VG. Wrote the paper: MJZ VG.
References
1. Furie B, Furie BC (2008) Mechanisms of thrombus formation. N Engl J Med
359: 938–949.
2. Phipps RP, Kaufman J, Blumberg N (2001) Platelet derived CD154 (CD40
ligand) and febrile responses to transfusion. Lancet 357: 2023–2024.
3. Gawaz M, Langer H, May AE (2005) Platelets in inflammation and
atherogenesis. J Clin Invest 115: 3378–3384.
4. Cardigan R, Turner C, Harrison P (2005) Current methods of assessing platelet
function: relevance to transfusion medicine. Vox Sang 88: 153–163.
5. Coller BS, Shattil SJ (2008) The GPIIb/IIIa (integrin alphaIIbbeta3) odyssey: a
technology-driven saga of a receptor with twists, turns, and even a bend. Blood
112: 3011–3025.
6. Shattil SJ, Newman PJ (2004) Integrins: dynamic scaffolds for adhesion and
signaling in platelets. Blood 104: 1606–1615.
7. Bennett JS, Vilaire G (1979) Exposure of platelet fibrinogen receptors by ADP
and epinephrine. J Clin Invest 64: 1393–1401.
8. Wagner CL, Mascelli MA, Neblock DS, Weisman HF, Coller BS, et al. (1996)
Analysis of GPIIb/IIIa receptor number by quantification of 7E3 binding to
human platelets. Blood 88: 907–914.
9. Gnatenko DV, Perrotta PL, Bahou WF (2006) Proteomic approaches to dissect
platelet function: Half the story. Blood 108: 3983–3991.
10. Cagney G, McRedmond J (2008) A central resource for platelet proteomics.
Arterioscler Thromb Vasc Biol 28: 1214–1215.
11. Dittrich M, Birschmann I, Mietner S, Sickmann A, Walter U, et al. (2008)
Platelet protein interactions: map, signaling components, and phosphorylation
groundstate. Arterioscler Thromb Vasc Biol 28: 1326–1331.
12. MacDonald JA, Mackey AJ, Pearson WR, Haystead TA (2002) A strategy for
the rapid identification of phosphorylation sites in the phosphoproteome. Mol
Cell Proteomics 1: 314–322.
13. Marcus K, Immler D, Sternberger J, Meyer HE (2000) Identification of platelet
proteins separated by two-dimensional gel electrophoresis and analyzed by
matrix assisted laser desorption/ionization-time of flight-mass spectrometry and
detection of tyrosine-phosphorylated proteins. Electrophoresis 21: 2622–2636.
14. Maguire PB, Wynne KJ, Harney DF, O’Donoghue NM, Stephens G, et al.
(2002) Identification of the phosphotyrosine proteome from thrombin activated
platelets. Proteomics 2: 642–648.
15. Garcia A, Prabhakar S, Hughan S, Anderson TW, Brock CJ, et al. (2004)
Differential proteome analysis of TRAP-activated platelets: involvement of
DOK-2 and phosphorylation of RGS proteins. Blood 103: 2088–2095.
16. Garcia A, Senis YA, Antrobus R, Hughes CE, Dwek RA, et al. (2006) A global
proteomics approach identifies novel phosphorylated signaling proteins in
GPVI-activated platelets: involvement of G6f, a novel platelet Grb2-binding
membrane adapter. Proteomics 6: 5332–5343.
17. Zahedi RP, Lewandrowski U, Wiesner J, Wortelkamp S, Moebius J, et al. (2008)
Phosphoproteome of resting human platelets. J Proteome Res 7: 526–534.
18. Marcus K, Moebius J, Meyer HE (2003) Differential analysis of phosphorylated
proteins in resting and thrombin-stimulated human platelets. Anal Bioanal
Chem 376: 973–993.
19. Immler D, Gremm D, Kirsch D, Spengler B, Presek P, et al. (1998) Identification
of phosphorylated proteins from thrombin-activated human platelets isolated by
two-dimensional gel electrophoresis by electrospray ionization-tandem mass
spectrometry (ESI-MS/MS) and liquid chromatography-electrospray ionization-
mass spectrometry (LC-ESI-MS). Electrophoresis 19: 1015–1023.
20. Winkler W, Zellner M, Diestinger M, Babeluk R, Marchetti M, et al. (2008)
Biological variation of the platelet proteome in the elderly population and its
implication for biomarker research. Mol Cell Proteomics 7: 193–203.
21. Murakami T, Komiyama Y, Masuda M, Kido H, Nomura S, et al. (1996) Flow
cytometric analysis of platelet activation markers CD62P and CD63 in patients
with coronary artery disease. Eur J Clin Invest 26: 996–1003.
22. Bagamery K, Kvell K, Barnet M, Landau R, Graham J (2005) Are platelets
activated after a rapid, one-step density gradient centrifugation? Evidence from
flow cytometric analysis. Clin Lab Haematol 27: 75–77.
23. Curvers J, de Wildt-Eggen J, Heeremans J, Scharenberg J, de Korte D, et al.
(2008) Flow cytometric measurement of CD62P (P-selectin) expression on
platelets: a multicenter optimization and standardization effort. Transfusion 48:
1439–1446.
24. Verhallen PF, Bevers EM, Comfurius P, Zwaal RF (1987) Correlation between
calpain-mediated cytoskeletal degradation and expression of platelet procoag-
ulant activity. A role for the platelet membrane-skeleton in the regulation of
membrane lipid asymmetry? Biochim Biophys Acta 903: 206–217.
25. Anagli J, Hagmann J, Shaw E (1991) Investigation of the role of calpain as a
stimulus-response mediator in human platelets using new synthetic inhibitors.
Biochem J 274 ( Pt 2): 497–502.
26. Hayashi M, Suzuki H, Kawashima S, Saido TC, Inomata M (1999) The
behavior of calpain-generated N- and C-terminal fragments of talin in integrin-
mediated signaling pathways. Arch Biochem Biophys 371: 133–141.
27. Calderwood DA, Zent R, Grant R, Rees DJ, Hynes RO, et al. (1999) The Talin
head domain binds to integrin beta subunit cytoplasmic tails and regulates
integrin activation. J Biol Chem 274: 28071–28074.
28. Greening DW, Glenister KM, Kapp EA, Moritz RL, Sparrow RL, et al. (2008)
Comparison of human platelet membrane-cytoskeletal proteins with the plasma
proteome: Towards understanding the platelet-plasma nexus. Proteomics Clin
Appl 2: 63–77.
29. Greening DW, Glenister KM, Sparrow RL, Simpson RJ (2009) Enrichment of
human platelet membranes for proteomic analysis. Methods Mol Biol 528:
245–258.
30. Coppinger JA, Cagney G, Toomey S, Kislinger T, Belton O, et al. (2004)
Characterization of the proteins released from activated platelets leads to
localization of novel platelet proteins in human atherosclerotic lesions. Blood
103: 2096–2104.
31. Claeys D, Geering K, Meyer BJ (2005) Two-dimensional Blue Native/sodium
dodecyl sulfate gel electrophoresis for analysis of multimeric proteins in platelets.
Electrophoresis 26: 1189–1199.
32. O’Neill EE, Brock CJ, von Kriegsheim AF, Pearce AC, Dwek RA, et al. (2002)
Towards complete analysis of the platelet proteome. Proteomics 2: 288–305.
33. Moebius J, Zahedi RP, Lewandrowski U, Berger C, Walter U, et al. (2005) The
human platelet membrane proteome reveals several new potential membrane
proteins. Mol Cell Proteomics 4: 1754–1761.
34. Garcia BA, Smalley DM, Cho H, Shabanowitz J, Ley K, et al. (2005) The
platelet microparticle proteome. J Proteome Res 4: 1516–1521.
35. Garcia A, Prabhakar S, Brock CJ, Pearce AC, Dwek RA, et al. (2004) Extensive
analysis of the human platelet proteome by two-dimensional gel electrophoresis
and mass spectrometry. Proteomics 4: 656–668.
36. Martens L, Van Damme P, Van Damme J, Staes A, Timmerman E, et al. (2005)
The human platelet proteome mapped by peptide-centric proteomics: a
functional protein profile. Proteomics 5: 3193–3204.
37. Senis YA, Tomlinson MG, Garcia A, Dumon S, Heath VL, et al. (2007) A
comprehensive proteomics and genomics analysis reveals novel transmembrane
proteins in human platelets and mouse megakaryocytes including G6b-B, a
novel immunoreceptor tyrosine-based inhibitory motif protein. Mol Cell
Proteomics 6: 548–564.
A Contextual Platelet PPIN
PLoS ONE | www.plosone.org 15 October 2009 | Volume 4 | Issue 10 | e762738. Carrell NA, Fitzgerald LA, Steiner B, Erickson HP, Phillips DR (1985) Structure
of human platelet membrane glycoproteins IIb and IIIa as determined by
electron microscopy. J Biol Chem 260: 1743–1749.
39. Zahedi RP, Begonja AJ, Gambaryan S, Sickmann A (2006) Phosphoproteomics
of human platelets: A quest for novel activation pathways. Biochim Biophys Acta
1764: 1963–1976.
40. Posewitz MC, Tempst P (1999) Immobilized gallium(III) affinity chromatogra-
phy of phosphopeptides. Anal Chem 71: 2883–2892.
41. Muszynska G, Dobrowolska G, Medin A, Ekman P, Porath JO (1992) Model
studies on iron(III) ion affinity chromatography. II. Interaction of immobilized
i r o n ( I I I )i o n sw i t hp h o s p h o r y l a t e da m i n oa c i d s ,p e p t i d e sa n dp r o t e i n s .
J Chromatogr 604: 19–28.
42. Olsen JV, Blagoev B, Gnad F, Macek B, Kumar C, et al. (2006) Global, in vivo,
and site-specific phosphorylation dynamics in signaling networks. Cell 127:
635–648.
43. Villen J, Beausoleil SA, Gerber SA, Gygi SP (2007) Large-scale phosphorylation
analysis of mouse liver. Proc Natl Acad Sci U S A 104: 1488–1493.
44. Schwartz D, Gygi SP (2005) An iterative statistical approach to the identification
of protein phosphorylation motifs from large-scale data sets. Nat Biotechnol 23:
1391–1398.
45. Crooks GE, Hon G, Chandonia JM, Brenner SE (2004) WebLogo: a sequence
logo generator. Genome Res 14: 1188–1190.
46. Amanchy R, Periaswamy B, Mathivanan S, Reddy R, Tattikota SG, et al. (2007)
A curated compendium of phosphorylation motifs. Nat Biotechnol 25: 285–286.
47. Calvano SE, Xiao W, Richards DR, Felciano RM, Baker HV, et al. (2005) A
network-based analysis of systemic inflammation in humans. Nature 437:
1032–1037.
48. Venkatesan K, Rual JF, Vazquez A, Stelzl U, Lemmens I, et al. (2009) An
empirical framework for binary interactome mapping. Nat Methods 6: 83–90.
49. Cusick ME, Klitgord N, Vidal M, Hill DE (2005) Interactome: gateway into
systems biology. Hum Mol Genet 14 Spec No. 2: R171–181.
50. Yu H, Braun P, Yildirim MA, Lemmens I, Venkatesan K, et al. (2008) High-
quality binary protein interaction map of the yeast interactome network. Science
322: 104–110.
51. Braun P, Tasan M, Dreze M, Barrios-Rodiles M, Lemmens I, et al. (2009) An
experimentally derived confidence score for binary protein-protein interactions.
Nat Methods 6: 91–97.
52. Rual JF, Venkatesan K, Hao T, Hirozane-Kishikawa T, Dricot A, et al. (2005)
Towards a proteome-scale map of the human protein-protein interaction
network. Nature 437: 1173–1178.
53. Goh KI, Cusick ME, Valle D, Childs B, Vidal M, et al. (2007) The human
disease network. Proc Natl Acad Sci U S A 104: 8685–8690.
54. Keshava Prasad TS, Goel R, Kandasamy K, Keerthikumar S, Kumar S, et al.
(2009) Human Protein Reference Database–2009 update. Nucleic Acids Res 37:
D767–772.
55. Shannon P, Markiel A, Ozier O, Baliga NS, Wang JT, et al. (2003) Cytoscape: a
software environment for integrated models of biomolecular interaction
networks. Genome Res 13: 2498–2504.
56. Zaidel-Bar R, Itzkovitz S, Ma’ayan A, Iyengar R, Geiger B (2007) Functional
atlas of the integrin adhesome. Nat Cell Biol 9: 858–867.
57. Bader GD, Hogue CW (2003) An automated method for finding molecular
complexes in large protein interaction networks. BMC Bioinformatics 4: 2.
58. Kirk RI, Sanderson MR, Lerea KM (2000) Threonine phosphorylation of the
beta 3 integrin cytoplasmic tail, at a site recognized by PDK1 and Akt/PKB in
vitro, regulates Shc binding. J Biol Chem 275: 30901–30906.
59. Lerea KM, Venjara AY, Olson SC, Kelly MR (2007) Threonine phosphory-
lation of integrin beta3 in calyculin A-treated platelets is selectively sensitive to
59-iodotubercidin. Biochim Biophys Acta 1773: 185–191.
60. Lerea KM, Cordero KP, Sakariassen KS, Kirk RI, Fried VA (1999)
Phosphorylation sites in the integrin beta3 cytoplasmic domain in intact
platelets. J Biol Chem 274: 1914–1919.
61. Cowan KJ, Law DA, Phillips DR (2000) Identification of shc as the primary
protein binding to the tyrosine-phosphorylated beta 3 subunit of alpha IIbbeta 3
during outside-in integrin platelet signaling. J Biol Chem 275: 36423–36429.
62. Obergfell A, Eto K, Mocsai A, Buensuceso C, Moores SL, et al. (2002)
Coordinate interactions of Csk, Src, and Syk kinases with [alpha]IIb[beta]3
initiate integrin signaling to the cytoskeleton. J Cell Biol 157: 265–275.
63. Vijayan KV, Liu Y, Li TT, Bray PF (2004) Protein phosphatase 1 associates with
the integrin alphaIIb subunit and regulates signaling. J Biol Chem 279:
33039–33042.
64. Sato K, Nagao T, Kakumoto M, Kimoto M, Otsuki T, et al. (2002) Adaptor
protein Shc is an isoform-specific direct activator of the tyrosine kinase c-Src.
J Biol Chem 277: 29568–29576.
65. Palmer-Toy DE, Krastins B, Sarracino DA, Nadol JB Jr, Merchant SN (2005)
Efficient method for the proteomic analysis of fixed and embedded tissues.
J Proteome Res 4: 2404–2411.
66. Pruitt KD, Tatusova T, Maglott DR (2005) NCBI Reference Sequence
(RefSeq): a curated non-redundant sequence database of genomes, transcripts
and proteins. Nucleic Acids Res 33: D501–504.
67. Moore RE, Young MK, Lee TD (2002) Qscore: an algorithm for evaluating
SEQUEST database search results. J Am Soc Mass Spectrom 13: 378–386.
A Contextual Platelet PPIN
PLoS ONE | www.plosone.org 16 October 2009 | Volume 4 | Issue 10 | e7627